FAIR Health has launched a new Opioid Tracker, featuring heat maps representing opioid abuse and dependence claim lines in the United States.
Today FAIR Health launched the Opioid Tracker, a free, interactive tool tracking opioid abuse and dependence state by state. A brief released simultaneously offers a user’s guide to the Opioid Tracker.
Available on FAIR Health’s website fairhealth.org, the Opioid Tracker includes a heat map representing opioid abuse and dependence claim lines as a percentage of all medical claim lines in 2022 state by state. Clicking on a state displays an infographic for that state. The infographic includes the top 5 procedure codes by utilization for opioid abuse and dependence, the top 5 procedure codes by aggregate allowed amounts for opioid abuse and dependence, the change in opioid abuse and dependence claim lines as a percentage of all medical claim lines from 2018 to 2022, and diagnoses of opioid abuse and dependence by age and gender. There is also a similar infographic for the nation as a whole. The source of the data is FAIR Health’s repository of more than 42 billion private health care claim records, the largest such repository in the nation.
Among the key findings revealed by the Opioid Tracker:
The Opioid Tracker is the latest addition to FAIR Health’s series of trackers offering geographic windows into health care data. The series also includes the Monthly Telehealth Regional Tracker, which tracks telehealth utilization by region across the nation; and the Cost of Giving Birth Tracker, which shows state-specific and national median costs for vaginal deliveries and C-sections.
The Opioid Tracker sheds light on multiple aspects of opioid abuse and dependence, including utilization, costs, age and gender. We hope that the Opioid Tracker will be useful to all health care stakeholders, such as policy makers, payors, providers, patients, and researchers, as they continue to track and seek to better understand and address this public health issue.
For the Opioid Tracker, click here. For the user’s guide to the Opioid Tracker, click here.
Bimekizumab Shows Sustained Efficacy in Treating Axial Spondyloarthritis for 52 Weeks
April 30th 2024Results from a study presented at the Academy of Managed Care Pharmacy 2024 annual meeting demonstrated sustained efficacy of bimekizumab compared with placebo in patients with non-radiographic and radiographic axial spondyloarthritis (axSpA) at week 52.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More